Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3-Induced Myocarditis and Antiviral Drug Screening Platform

被引:114
|
作者
Sharma, Arun [1 ,2 ,3 ,4 ]
Marceau, Caleb [5 ]
Hamaguchi, Ryoko [1 ,2 ,3 ,4 ]
Burridge, Paul W. [1 ,2 ,3 ]
Rajarajan, Kuppusamy [1 ,2 ,3 ]
Churko, Jared M. [1 ,2 ,3 ]
Wu, Haodi [1 ,2 ,3 ]
Sallam, Karim I. [1 ,2 ,3 ]
Matsa, Elena [1 ,2 ,3 ]
Sturzu, Anthony C. [1 ,2 ,3 ]
Che, Yonglu [1 ,2 ,3 ]
Ebert, Antje [1 ,2 ,3 ]
Diecke, Sebastian [1 ,2 ,3 ]
Liang, Ping [1 ,2 ,3 ]
Red-Horse, Kristy [3 ,4 ]
Carette, Jan E. [5 ]
Wu, Sean M. [1 ,2 ,3 ]
Wu, Joseph C. [1 ,2 ,3 ,6 ]
机构
[1] Stanford Univ, Sch Med, Div Cardiol, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Biol, Stanford, CA 94305 USA
[5] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[6] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
myocarditis; myocytes; cardiac; stem cells; ADENOVIRUS-RECEPTOR; INTERFERON-BETA; INHIBITION; DIFFERENTIATION; REPLICATION; MECHANISMS; FLUOXETINE; EXPRESSION; MATURATION; INFECTION;
D O I
10.1161/CIRCRESAHA.115.303810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Viral myocarditis is a life-threatening illness that may lead to heart failure or cardiac arrhythmias. A major causative agent for viral myocarditis is the B3 strain of coxsackievirus, a positive-sense RNA enterovirus. However, human cardiac tissues are difficult to procure in sufficient enough quantities for studying the mechanisms of cardiac-specific viral infection. Objective: This study examined whether human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) could be used to model the pathogenic processes of coxsackievirus-induced viral myocarditis and to screen antiviral therapeutics for efficacy. Methods and Results: hiPSC-CMs were infected with a luciferase-expressing coxsackievirus B3 strain (CVB3-Luc). Brightfield microscopy, immunofluorescence, and calcium imaging were used to characterize virally infected hiPSC-CMs for alterations in cellular morphology and calcium handling. Viral proliferation in hiPSC-CMs was quantified using bioluminescence imaging. Antiviral compounds including interferon beta 1, ribavirin, pyrrolidine dithiocarbamate, and fluoxetine were tested for their capacity to abrogate CVB3-Luc proliferation in hiPSC-CMs in vitro. The ability of these compounds to reduce CVB3-Luc proliferation in hiPSC-CMs was consistent with reported drug effects in previous studies. Mechanistic analyses via gene expression profiling of hiPSC-CMs infected with CVB3-Luc revealed an activation of viral RNA and protein clearance pathways after interferon beta 1 treatment. Conclusions: This study demonstrates that hiPSC-CMs express the coxsackievirus and adenovirus receptor, are susceptible to coxsackievirus infection, and can be used to predict antiviral drug efficacy. Our results suggest that the hiPSC-CM/CVB3-Luc assay is a sensitive platform that can screen novel antiviral therapeutics for their effectiveness in a high-throughput fashion.
引用
收藏
页码:556 / +
页数:34
相关论文
共 50 条
  • [1] Strategies for Improving the Maturity of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Tu, Chengyi
    Chao, Benjamin S.
    Wu, Joseph C.
    CIRCULATION RESEARCH, 2018, 123 (05) : 512 - 514
  • [2] Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes
    Sun, Xuetao
    Nunes, Sara S.
    METHODS, 2016, 101 : 21 - 26
  • [3] Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis
    Mueller, Irene
    Janson, Lisa
    Sauter, Martina
    Pappritz, Kathleen
    Linthout, Sophie Van
    Tschoepe, Carsten
    Klingel, Karin
    VIRUSES-BASEL, 2021, 13 (05):
  • [4] Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes
    Yun, Soo-Hyeon
    Shin, Ha-Hyeon
    Ju, Eun-Seon
    Lee, You-Jung
    Lim, Byung-Kwan
    Jeon, Eun-Seok
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [5] The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening
    Khan, Jaffar M.
    Lyon, Alexander R.
    Harding, Sian E.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (02) : 304 - 317
  • [6] Screening Drug-Induced Arrhythmia Events Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays
    Navarrete, Enrique G.
    Liang, Ping
    Lan, Feng
    Sanchez-Freire, Veronica
    Simmons, Chelsey
    Gong, Tingyu
    Sharma, Arun
    Burridge, Paul W.
    Patlolla, Bhagat
    Lee, Andrew S.
    Wu, Haodi
    Beygui, Ramin E.
    Wu, Sean M.
    Robbins, Robert C.
    Bers, Donald M.
    Wu, Joseph C.
    CIRCULATION, 2013, 128 (11) : S3 - U51
  • [7] Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types
    Doherty, Kimberly R.
    Talbert, Dominique R.
    Trusk, Patricia B.
    Moran, Diarmuid M.
    Shell, Scott A.
    Bacus, Sarah
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2015, 285 (01) : 51 - 60
  • [8] Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity
    Sharma, Arun
    McKeithan, Wesley L.
    Serrano, Ricardo
    Kitani, Tomoya
    Burridge, Paul W.
    del Alamo, Juan C.
    Mercola, Mark
    Wu, Joseph C.
    NATURE PROTOCOLS, 2018, 13 (12) : 3018 - 3041
  • [9] Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes
    Johnson, Robert D.
    Lei, Ming
    Mcvey, John H.
    Camelliti, Patrizia
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (09)
  • [10] Drug Screening Using a Library of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity
    Liang, Ping
    Lan, Feng
    Lee, Andrew S.
    Gong, Tingyu
    Sanchez-Freire, Veronica
    Wang, Yongming
    Diecke, Sebastian
    Sallam, Karim
    Knowles, Joshua W.
    Wang, Paul J.
    Nguyen, Patricia K.
    Bers, Donald M.
    Robbins, Robert C.
    Wu, Joseph C.
    CIRCULATION, 2013, 127 (16) : 1677 - +